TABLE 3.
Relative risk (95% CIs) of early versus late incident non-fatal MI, fatal CHD, and CABG/PCTA by tertiles of Lp-PLA2 activity among 1,517 male and female diabetic subjects from the HPFS and NHS
Tertiles of Lp-PLA2 |
P for trend | |||
---|---|---|---|---|
1 | 2 | 3 | ||
Total CHD within 6 years (n = 1,517) | 28 | 43 | 67 | |
Age adjusted | 1.0 | 1.70 (1.04–2.77) | 2.41 (1.51–3.84) | <0.001 |
Multivariate adjusted* | 1.0 | 1.72 (1.03–2.86) | 2.34 (1.42–3.86) | <0.001 |
Multivariate adjusted + LDL | 1.0 | 1.57 (0.93–2.65) | 2.00 (1.16–3.44) | 0.012 |
Total CHD after 6 years (n = 1,309)† | 54 | 54 | 78 | |
Age adjusted | 1.0 | 1.10 (0.75–1.62) | 1.65 (1.15–2.37) | 0.005 |
Multivariate adjusted* | 1.0 | 1.10 (0.73–1.63) | 1.51 (1.02–2.23) | 0.039 |
Multivariate adjusted + LDL | 1.0 | 0.98 (0.65–1.47) | 1.23 (0.81–1.89) | 0.323 |
Results were pooled between men and women using inverse variance weights.
*Multivariate relative risks adjusted for age, fasting status, smoking, alcohol intake, physical activity, duration of diabetes, aspirin use, cholesterol-lowering medication use, family history of MI, history of hypertension, BMI, HDL, A1C, C-reactive protein, intercellular adhesion molecule, insulin use, waist circumference, estimated glomerular filtration rate, and hormone replacement therapy use (women only).
†Follow-up began 6 years after blood draw. Participants who sustained a nonfatal MI or fatal CHD or were lost to follow-up before year 6 were not considered at risk for a cardiovascular event after 6 years.